Monoclonal Antibody News and Research

RSS
Monoclonal antibodies (MAbs) are produced from a single B cell clone and can bind to a single type of antigen binding site. MAbs are homogenous antibodies that cannot form lattices with monomeric proteins as they can bind to only a single epitope on the antigen. Developed in the 1970s, MAbs can be produced against any given substance. Thus they can be used to detect and purify any substance of interest. This has made MAbs a powerful tool of molecular biology, biochemistry, and medicine.
Promising new antivirals target arboviruses and SARS-CoV-2: Nodosome inhibitors

Promising new antivirals target arboviruses and SARS-CoV-2: Nodosome inhibitors

Novel super-activating macrophage receptor could explain hyper-inflammation in severe COVID-19

Novel super-activating macrophage receptor could explain hyper-inflammation in severe COVID-19

Custom Rabbit and Mouse Recombinant Monoclonal Antibodies

Custom Rabbit and Mouse Recombinant Monoclonal Antibodies

Scientists identify neutralizing human monoclonal antibodies against SARS-CoV-2

Scientists identify neutralizing human monoclonal antibodies against SARS-CoV-2

Thermo Fisher Scientific and Symphogen extend collaboration to boost drug discovery and development

Thermo Fisher Scientific and Symphogen extend collaboration to boost drug discovery and development

UIC enrolls people into phase 3 monoclonal antibody clinical trial

UIC enrolls people into phase 3 monoclonal antibody clinical trial

COVID-19 study: Researchers recruit frontline workers to identify asymptomatic individuals

COVID-19 study: Researchers recruit frontline workers to identify asymptomatic individuals

MD65 IgG-YTE shows powerful post-exposure neutralization of SARS-CoV-2

MD65 IgG-YTE shows powerful post-exposure neutralization of SARS-CoV-2

Researchers demonstrate potent antibody that fights against coronavirus

Researchers demonstrate potent antibody that fights against coronavirus

Monoclonal Antibodies: Discovery, Characterization and Challenges

Monoclonal Antibodies: Discovery, Characterization and Challenges

Spike protein of SARS-CoV-2 virus identifies and binds neuropilin-1 on human cells to infect them

Spike protein of SARS-CoV-2 virus identifies and binds neuropilin-1 on human cells to infect them

3D imaging of SARS-CoV-2 infection in ferrets using light sheet microscopy

3D imaging of SARS-CoV-2 infection in ferrets using light sheet microscopy

Can ordinary COVID patients get the Trump treatment? It’s OK to ask

Can ordinary COVID patients get the Trump treatment? It’s OK to ask

New inhaled treatment may lead to self-administered therapy for COVID-19

New inhaled treatment may lead to self-administered therapy for COVID-19

FDA approves Regeneron antibody drug as first treatment for Ebola virus

FDA approves Regeneron antibody drug as first treatment for Ebola virus

NIH launches new study to streamline COVID-19 treatments for larger clinical studies

NIH launches new study to streamline COVID-19 treatments for larger clinical studies

New clinical trial to test safety and efficacy of antibody cocktail against COVID-19

New clinical trial to test safety and efficacy of antibody cocktail against COVID-19

As Trump touts his ‘great’ COVID drugs, the pharma cash flows to Biden, not him

As Trump touts his ‘great’ COVID drugs, the pharma cash flows to Biden, not him

Novel radioimmunotherapy proven effective in reversing resistance to lymphoma therapy

Novel radioimmunotherapy proven effective in reversing resistance to lymphoma therapy

Proteolytic cleavage of nucleocapsid helps SARS-CoV-2 evade host immune responses

Proteolytic cleavage of nucleocapsid helps SARS-CoV-2 evade host immune responses